ActuateCare

ActuateCare sells AI-driven remote-care software sold on an annual SaaS license; tiers run mid-range to premium depending on covered patient volume and analytics modules. The core platform streams data from Bluetooth vitals monitors, EHRs and patient smartphones into clinician dashboards; add-ons include predictive analytics, automated billing and 24/7 tele-nurse triage. All sales are B2B through the company website and direct enterprise reps; no consumer hardware is retailed. The brand’s positioning is “hospital-at-home in 30 days,” promising deployment without new capital equipment. Its FDA-cleared predictive engine flags patient deterioration six hours faster than baseline EHR alerts, cutting readmissions 22 % in published health-system studies. Notable offerings include the Rapid-Deploy Kit (pre-paired devices shipped to patient homes) and the ActuateIQ analytics layer that risk-stratifies entire populations in real time. Buyers are medium-to-large health systems, Medicare Advantage plans and post-acute operators shifting care to the home to hit CMS quality bonuses. Decision-makers value reduced LOS, penalty avoidance and patient satisfaction scores; the platform’s turnkey logistics appeals to IT teams facing staffing shortages. The implicit brand promise is safer, reimbursable care at home without added clinician workload. Competitors include venture-backed remote-monitoring platforms and legacy device vendors building cloud portals. ActuateCare differentiates through zero-capital implementation, interoperable BYOD connectivity and outcome-based contracts that let hospitals pay from avoided-penalty savings rather than upfront CapEx.